To download b-roll video footage associated with this
release please visit:
http://www.multivu.com/players/English/7601551-cnw-vod/
TORONTO, Aug. 17, 2015
/CNW/ - Mettrum Health Corp. (Mettrum™) (TSXV:MT) (TSXV:MT.WT), a
vertically integrated agri-pharmaceutical company focused on
research, development, production and distribution of Health Canada
licensed cannabis products, has made educating and resourcing
healthcare practitioners and their patients across Canada a top priority, resulting in continued
industry leadership and strong company growth. Reported on
August 12, 2015, the company achieved
a 20 per cent increase in the number of Mettrum registered clients
and a 47 per cent increase in revenue for the first quarter fiscal
2016 financial results for the period ended June 30, 2015 compared to the previous
quarter.
Mettrum is one of Canada's
first licensed producers, receiving its license from Health Canada
on November 1, 2013 to produce and
sell dried cannabis to eligible persons under the Marihuana for
Medical Purposes Regulations (MMPR). Mettrum operates
two state-of-the-art indoor facilities in Ontario and recently received approval from
Health Canada to increase production capacity by nearly 300 per
cent at its Agripharm ("Mettrum Creemore") facility.
"As a pioneering licensed producer in Canada with decades of combined expertise in
the agri-pharma, pharmaceutical, distribution and technology
industries, Mettrum is well positioned to be at the forefront in
the minds of healthcare practitioners and patients who choose
medical cannabis to help treat a wide range of medical conditions,"
said Michael Haines, CEO of Mettrum
Health Corp. "Mettrum's current and future activities will always
be rooted in our commitment to ongoing research, quality
production, superior service and support for Canadian healthcare
practitioners and their patients."
In addition to the company's business and production growth,
Mettrum continues to develop innovative tools designed for the
1,500+ physicians who have prescribed medical cannabis to Mettrum
clients:
- Mettrum Spectrum™ is designed to simplify the dialogue around
medical cannabis by categorizing Mettrum strains according to THC
potency, as well as CBD levels.
- Mettrum's Medical Cannabis EMR™ (Electronic Medical Record) is
a secure and comprehensive web-based portal built for physicians.
The EMR allows physicians to easily register, review and renew
their patients' prescriptions.
"The Mettrum Spectrum is an excellent tool to select the strain
of medical cannabis that best fits my patients' profiles
as it's a simple colour coding system for cannabis,
instead of street names I am not comfortable using," said Dr.
Andrew B. Cooper MD MHSC
FRCPC, Clinical Director, Caledon Medical Cannabinoid Clinic
and Adjunct Professor, University of
Toronto Department of Anesthesia. "For new patients,
the Mettrum Spectrum helps me communicate about medical
cannabis and follow the College of Family Physicians
Canada's guidelines for prescribing. For patients on an
established Cannabinoid therapy, the Mettrum
Spectrum helps me titrate the dosage in a
straightforward, stepwise manner."
Mettrum is actively involved in innovative research that
contributes to the ongoing study of medical cannabis. One of the
company's most recent investments in research includes becoming a
key funding partner in the creation of the first registry for
medical cannabis patients in the Province of Quebec. This innovative project by the
Research Institute of the McGill
University Health Centre (RI-MUHC) and the Canadian
Consortium for the Investigation of Cannabinoids (CCIC) represents
the world's first research database on the use of cannabis for
medical purposes and will allow healthcare practitioners to better
monitor patient safety.
For more information on Mettrum please visit mettrum.com.
Individuals interested in medical cannabis should speak with a
Mettrum client service representative at 1-844-METTRUM to obtain
information on the process.
About Mettrum Health Corp.
Mettrum Health Corp. is Tier 1 Industry Issuer listed on TSX
Venture Exchange. Mettrum Ltd., a wholly-owned subsidiary of the
Company, is a Toronto-based
company and a licensed producer of medical cannabis under
the Marihuana for Medical Purposes
Regulations (Canada)
issued pursuant to the Controlled Drugs and Substances
Act (Canada) (the
"MMPR"), which came into effect on October
1, 2013. Mettrum received its first license from Health
Canada under the MMPR on November 1,
2013 and began production of medical cannabis on the same
date at its first production facility in Bowmanville, Ontario. Mettrum received its
second license from Health Canada under the MMPR on December 11, 2014 for its other wholly-owned
subsidiary, Agripharm Corp., at Agripharm's facility in
Clearview, Ontario. With the Company's two licenses,
Mettrum is a leading producer and vendor of medical marijuana under
the MMPR system.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION:
This news release includes certain "forward-looking statements"
under applicable Canadian securities legislation. Forward-looking
statements are necessarily based upon a number of estimates and
assumptions that, while considered reasonable, are subject to known
and unknown risks, uncertainties, and other factors which may cause
the actual results and future events to differ materially from
those expressed or implied by such forward-looking statements. Such
factors include, but are not limited to: general business,
economic, competitive, political and social uncertainties; delay or
failure to receive board, shareholder or regulatory approvals; and
the results of operations. There can be no assurance that such
statements will prove to be accurate, as actual results and future
events could differ materially from those anticipated in such
statements. Accordingly, readers should not place undue reliance on
forward-looking statements. The Company and Mettrum disclaim any
intention or obligation to update or revise any forward-looking
statements, whether as a result of new information, future events
or otherwise, except as required by law.
Neither the Exchange nor its Regulation Services Provider
(as that term is defined in the policies of the Exchange) accepts
responsibility for the adequacy or accuracy of this Press
release.
SOURCE Mettrum Health Corp.
